LOX and central nervous system cancer: The results revealed a significant increase in mRNA levels of the LOX family in 13 types of cancer, including GBM (glioblastoma, WHO grade IV) and LGG (low-grade glioma, WHO grade II-III), which indicates the potential pivotal role of the LOX family in neurogliomas (Figure 1A).